InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.33
(
0.48%
)
Bitcoin
58,534.94
(
-2.70%
)
Post# of 703817
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 89
Posts 17449
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: A deleted message

Saturday, 02/12/2022 8:27:39 AM

Saturday, February 12, 2022 8:27:39 AM

Post# of 703817

LL replied to an email from a poster here some years ago. Stated it was the same product. DC - Vax is the commercial name. ALT- DC is the name they use at UCLA.

This has been rehashed over and over again. It is just a way for the haters to spread doubt.


The assertion I made yesterday was that UCLA has a combo trial using a dc vaccine and Keytruda that is not related to DCVax-L.

It is this trial using a genetically engineered dc vaccine and Keytruda in lung cancer.

I also said that there are plenty of non DCVax-L ATl-DCs out there. APCEDEN or this trial as examples.

ATL DC is a type of DC vaccine. Just because the UCLA rGBM combo is using an ATL that is DCVax-L does not mean all the others are.

DD, KnowFear and Bala have created a pure strawman argument.
Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News
InvestorsHub NewsWire

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!